期刊档案 · ONCOLOGY
Journal of Cancer Survivorship
ISSN 1932-2259 · eISSN 1932-2267 · Springer US · UNITED STATES · 6 issues per year · 创刊 2007
Journal of Cancer Survivorship 中科院 医学 2区（2025 年升级版），影响因子 3.3，混合开放获取，APC 约 4,790 美元，近 24 个月 107 篇文章投稿到接收中位 91 天，2025 年发文 219 篇，SCIE、SSCI、Scopus 收录。
期刊官网公告即将转为完全开放获取：We are pleased to announce that Journal of Cancer Survivorship will become a fully open access (OA) on 1 January 2027. 原文 ↗出版商官网 ·
研究范围
研究范围与定位
Journal of Cancer Survivorship 由 Springer US 出版，属中科院医学大类（2025 升级版2区）。按 OpenAlex 近年发文统计，该刊主要发表 Cancer survivorship and care、Cancer-related cognitive impairment studies、Childhood Cancer Survivors' Quality of Life 等主题的论文，这 3 个主题约占 57.8%，主导子领域为 Oncology。（根据 OpenAlex 主题统计与中科院分区数据生成）
Announcement We are pleased to announce that Journal of Cancer Survivorship will become a fully open access (OA) on 1 January 2027. As a result, all submissions received from 8 September 2026 are subject to an article publication charge (APC) if accepted and published in the journal (unless a waiver is applied). Please see our FAQs which can be found at the bottom of this page for more information on APCs, funding options, waivers and the journal's transition to fully open access. The Journal of Cancer Survivorship: Research and Practice publishes original research on cancer survivors, systematic, and meta-analytic literature reviews, clinical investigations and policy-related research that can impact the quality of care and quality of life of cancer survivors. The journal publishes peer reviewed papers related to improving the understanding, prevention, and management of multiple areas related to cancer survivorship that can affect quality care, symptom management, function, and well-being.The number of cancer survivors continue to increase worldwide. This journal considers cancer survivors as individuals who were diagnosed with and treated for cancer (either living with or free of cancer), as well as those who after primary treatment continue to receive prolonged treatment. Studies can include adolescents or adults treated for cancer as children, as well as young adults, adults, or older adults. Research and practice involving all these types of cancer survivors is growing rapidly and dissemination of evidence-based information is essential for improved understanding and care. Publishes basic research, epidemiological studies, clinical investigations, health services and policy-related research Publishes systematic, meta-analytic and scoping reviews that adhere to the PRISMA reporting guidelines for systematic reviews/meta-analyses or the PRISMA extension for scoping reviews Improves understanding of survivorship topics affecting quality of care, health, function, and well-being Reflects growing interest consistent with increasing prevalence rates and future global impact For authors: Checklists to improve communication of quantitative or qualitative scientific researchMany papers that are published in JCS tend to follow various STROBE checklists https://www.strobe-statement.org/checklists/ or https://www.unisa.edu.au/contentassets/72bf75606a2b4abcaf7f17404af374ad/7c-10.1007_bf028206851.pdf or https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC1120242/ fo
摘自期刊官网 Aims & Scope
研究方向（LetPub）：ONCOLOGY
主编 Michael Feuerstein出版商官网
编委会国家分布：未见中国大陆编委；主要国家 美国 36、加拿大 3、澳大利亚 3、荷兰 3、中国香港 1（共 52 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Cancer survivorship and careMedicine34.4%
- Cancer-related cognitive impairment studiesMedicine11.8%
- Childhood Cancer Survivors' Quality of LifeMedicine11.6%
- Economic and Financial Impacts of CancerEconomics, Econometrics and Finance4.4%
- Family Support in IllnessSocial Sciences4.3%
- Cancer Risks and FactorsMedicine3.5%
- Global Cancer Incidence and ScreeningMedicine3.4%
- Physical Activity and HealthMedicine2.3%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 2 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 2 区 |
| 小类 | 肿瘤学ONCOLOGY | 3 区 |
| 小类 | 社会问题SOCIAL ISSUES | 3 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 2 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 2 区 |
| 小类 | 肿瘤学ONCOLOGY | 3 区 |
| 小类 | 社会问题SOCIAL ISSUES | 2 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）医学 2 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 2 区 |
| 小类 | 社会问题SOCIAL ISSUES | 2 区 |
| 小类 | 肿瘤学ONCOLOGY | 3 区 |
Top 期刊：否综述期刊：否
数据库收录
SCIESSCIScopusLetPub
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
MEDLINEPsycINFOCurrent Contents出版商官网
其他：Google Scholar、EBSCO、ProQuest、Dimensions、CNKI、Baidu、Naver、OCLC、Portico、CLOCKSS、Semantic Scholar
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 3.3LetPub ·
- 影响因子（出版商公布） 2025
- 3.4出版商官网 ·
- 五年影响因子（出版商公布） 2025
- 4.3出版商官网 ·
- CiteScore 2026-06
- 8.6LetPub ·
- SJR 2026-06
- 1.15LetPub ·
- SNIP 2026-06
- 1.43LetPub ·
- h-index
- 53LetPub ·
- h-index
- 109OpenAlex ·
- i10-index
- 1,201OpenAlex ·
- 两年平均被引
- 3.14OpenAlex ·
- 自引率
- 8.8%LetPub ·
- Gold OA 文章占比
- 47.42%LetPub ·
发文规模
- 年文章数
- 212LetPub ·
- 年发文量（出版商公布）
- 2,025出版商官网 ·
- 年下载量（出版商公布） 2025
- 1,100,000出版商官网 ·
逐年发文量 OpenAlex 统计 · 累计 2,098 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 168 | 106 | 62 |
| 2025 | 219 | 143 | 508 |
| 2024 | 222 | 156 | 1,342 |
| 2023 | 195 | 136 | 2,222 |
| 2022 | 181 | 125 | 2,966 |
| 2021 | 163 | 105 | 3,683 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 Crossref 登记的稿件日期 · 至
91 天投稿到接收中位数 · P25–P75 73 天 – 133 天
- 接收到上线
- 中位数 17 天（107 篇）
- 投稿到上线
- 中位数 112 天
- 样本
- 107 篇有投稿与接收日期的文章（窗口内共 443 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度（社区反馈）
- >12周，或约稿LetPub ·
- 投稿到首次决定
- 1 天出版商官网 ·
- 评审方式
- 单盲同行评审、双盲同行评审出版商官网
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
混合开放获取LetPub
订阅期刊，作者可付费选择开放获取发表。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 4,790 / EUR 3,690 / GBP 2,990 | — | — |
混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点3 项，摘自作者指南
- 摘要
- 150–250 词
- 关键词
- ≥ 4 个
- 参考文献格式
- 顺序编码制（按引用顺序编号）
接收的文章类型1 种
- editorialSingle-blind peer review This journal follows a single-blind reviewing procedure. Authors are therefore requested to submit a title page, containing title, all …未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、出版伦理、许可与版权、开放获取、同行评审、试验注册 / 报告规范
- AI 使用 Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
原文 ↗出版商官网 ·- 作者资格 Authorship principles
Structured abstract of 150 to 250 words with sections Purpose, Methods, Results, Conclusions, Implications for Cancer Survivors 模型摘要
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
原文 ↗出版商官网 ·- 利益冲突 Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
原文 ↗出版商官网 ·- 数据可用性 Data Availability
Optional data availability statement 模型摘要
This journal encourages authors to provide an optional statement of data availability in their article. Data Availability Statements should include information on where data supporting the results reported in the article can be found, including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. Data availability statements can also indicate whether …
原文 ↗出版商官网 ·- 出版伦理 Compliance with Ethical Standards
Ethics approval statement required for research involving human or animal subjects 模型摘要
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
原文 ↗出版商官网 ·- 许可与版权 Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
原文 ↗出版商官网 ·- 开放获取 Open access publishing
To find out more about publishing your work Open Access in Journal of Cancer Survivorship, including information on fees, funding and licences, visit our Open access publishing page. Back to top
原文 ↗出版商官网 ·- 同行评审 Single-blind peer review
Single-blind peer review 模型摘要
This journal follows a single-blind reviewing procedure. Authors are therefore requested to submit a title page, containing title, all author names, affiliations, and the contact information of the corresponding author. Any acknowledgements, disclosures, or funding information should also be included on this page. Back to top
原文 ↗出版商官网 ·- 试验注册 / 报告规范 Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Springer US
- 出版国家或地区
- UNITED STATES
- 出版语言
- English
- 出版周期
- 6 issues per year
- 创刊年份
- 2007
- ISSN
- 1932-2259
- 电子版 ISSN
- 1932-2267
- 官网最新一期
- Volume 20, Issue 4（2026 年 8 月）
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗LetPub
- 作者指南 ↗LetPub
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Journal of Cancer Survivorship 的常见问题
Journal of Cancer Survivorship 是中科院几区期刊？
2025 年升级版分区表中，Journal of Cancer Survivorship 为医学 2区，小类 肿瘤学 / 社会问题 3 区。2026 年新锐版分区表中为医学 2区。不同版本与大小类分区不能混用。
Journal of Cancer Survivorship 的影响因子是多少？
LetPub 汇总的最新公布影响因子为 3.3，CiteScore 为 8.6，h-index 为 109。
Journal of Cancer Survivorship 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）107 篇已发表文章登记的日期，投稿到接收的中位数为 91 天（四分位 73–133 天）；投稿社区反馈的平均审稿速度为超过 12 周。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Journal of Cancer Survivorship 的投稿格式要求是什么？
据期刊作者指南：摘要：150–250 词；关键词：≥ 4 个；参考文献格式：顺序编码制（按引用顺序编号）。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Journal of Cancer Survivorship 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 52 位编委中，没有中国大陆学者；人数最多的国家是 美国（36 位）、加拿大（3 位）、澳大利亚（3 位）。统计按编委会页面列出的机构国家计，仅供参考。
Journal of Cancer Survivorship 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Journal of Cancer Survivorship 被 SCIE、SSCI、Scopus 收录。期刊官网自述还被 MEDLINE、PsycINFO、Current Contents 收录，该清单未与各数据库逐一核对。
Journal of Cancer Survivorship 是开放获取期刊吗？版面费多少？
Journal of Cancer Survivorship 为混合开放获取。选择开放获取发表时APC 约 4,790 美元。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。